Skip to content

CAPRA and CAPRA-S score calculator for prostate cancer

The CAPRA points before surgery and the CAPRA-S points from the pathology report, and what the studies show for each score.

Dr. Petronio Melo, urologistA reference in prostate cancer
CRM-SP 157.598 · RQE 70.275
Reviewed by Dr. Petronio Melo on November 20, 2026
Book a consultation
Drawing of two prostates in cross-section, the left one with a tumour and the marks of the biopsy cores, some in purple, the right one as a removed specimen with inked edges, and above them a row of ten circles, the first ones filled in shades of blue
On this page

Quick answer

CAPRA is a score from 0 to 10, developed at the University of California, San Francisco, that adds up points for the PSA, the biopsy Gleason score, the stage, the percentage of cores with cancer and age.1 A score of 0 to 2 means low risk; 3 to 5, intermediate; 6 to 10, high.2 After prostatectomy, CAPRA-S does the same with the pathology report of the specimen, from 0 to 12 points.4 Both are ways of comparing risk, and the result is something to bring to your consultation.

Calculate CAPRA or CAPRA-S

For CAPRA, you will need your PSA at diagnosis, the biopsy report and what the urologist noted about the rectal exam. For CAPRA-S, your last PSA before surgery and the prostatectomy pathology report. Choose the score with the switch at the top.

Your answers stay in your browser. Nothing is sent, stored or saved in cookies, and everything is cleared when you close the page.

Which score would you like to calculate?
Your blood test result before the biopsy. Example: 7.5
Biopsy Gleason scoreIt is in the biopsy report. If there is more than one, use the highest.
Clinical stage on rectal exam (cT)CAPRA was designed for tumours up to cT3a. It does not apply to cT3b (seminal vesicles) or cT4.
The total number of cores in the report. Example: 12
Any grade counts. Example: 4
Your age today.

Result

Choose the score, fill in the fields, then tap Calculate the score.

The CAPRA points follow the table from the 2009 study, and the CAPRA-S points follow the 2011 study.2,4 If your biopsy report gives more than one grade, use the highest. The tables are just below, for anyone who wants to check the calculation.

The CAPRA points

ItemPoints
PSA (ng/mL): below 60
PSA (ng/mL): 6 to 101
PSA (ng/mL): 10.01 to 202
PSA (ng/mL): 20.01 to 303
PSA (ng/mL): above 304
Biopsy Gleason: primary and secondary up to 3 (3+3)0
Biopsy Gleason: primary up to 3 and secondary 4 or 5 (3+4, 3+5)1
Biopsy Gleason: primary 4 or 5 (4+3, 4+4, 5+4 and others)3
Clinical stage: cT1 or cT20
Clinical stage: cT3a1
Cores with cancer: up to one third (33%)0
Cores with cancer: more than one third1
Age: under 500
Age: 50 or over1

Notice how much the primary Gleason pattern weighs: 4+3 is worth 3 points, and 3+4 only 1. The 2005 and 2009 articles differ in two details. In 2005, a PSA of exactly 6 was worth 0 points, and men with a PSA below 2 were excluded; in 2009, a PSA of 0 to 2 was included in the 0-point level, and 6 became worth 1 point.1,2 The calculator follows 2009. For the cores, 2005 says "less than 34%" and 2009 says "up to 33%"; here, up to one third of the cores (4 of 12, for example) is worth 0 points.

What the CAPRA numbers show

In the original 2005 study, the authors followed men treated with surgery and measured how many were free of recurrence, defined as a PSA of 0.2 ng/mL or more on two occasions or a second treatment more than 6 months after surgery:1

CAPRARecurrence-free at 3 yearsRecurrence-free at 5 years
0 or 191%85%
289%81%
381%66%
481%59%
569%60%
654%34%
7 or more24%8%

In a multi-centre validation published in 2006, the chance of being recurrence-free at 5 years was 86% with CAPRA 0 or 1 and 21% with CAPRA 7 to 10.3

In 2009, the same group applied the score to 10,627 men, with all types of treatment together, and looked at metastasis and death:2

GroupMetastasis-free at 10 yearsNot died of prostate cancer at 10 yearsAlive at 10 years
Low (0 to 2)97.5%97.1%71.4%
Intermediate (3 to 5)93.3%91.6%59.7%
High (6 to 10)83.4%79.1%42.0%

The last column also counts deaths from other illnesses, which is why it is much lower than the others.

The CAPRA-S points

CAPRA-S uses the prostatectomy pathology report. The points came from the weight of each factor in the statistical model of the 2011 study, rounded to the nearest whole number.4

ItemPoints
PSA before surgery (ng/mL): up to 60
PSA before surgery (ng/mL): 6.01 to 101
PSA before surgery (ng/mL): 10.01 to 202
PSA before surgery (ng/mL): above 203
Specimen Gleason: 6 or lower0
Specimen Gleason: 3+41
Specimen Gleason: 4+32
Specimen Gleason: 8 to 103
Positive margin: yes2
Extracapsular extension: yes1
Seminal vesicle invasion: yes2
Lymph node with cancer: yes1

The theoretical maximum is 12, but the study grouped scores of 9 or more together. The groups are low (0 to 2), intermediate (3 to 5) and high (6 or more).4 The article has no option for when the lymph nodes were not removed; in that case, the calculator counts 0 points and says so in the result. This is the chance of being free of progression, which in the study meant a PSA above 0.2 ng/mL on two occasions or a second treatment at least 6 months after surgery:4

CAPRA-SProgression-free at 3 yearsProgression-free at 5 years
096.3%94.5%
195.3%91.0%
289.8%83.3%
380.7%72.8%
474.9%70.2%
563.1%42.5%
649.2%25.9%
750.9%26.9%
826.9%12.3%
9 or more7.3%0%

A positive margin alone is worth 2 points. The page on positive surgical margins explains what it means and what the studies show about radiotherapy after surgery.

What the scores do not show

The CAPRA-S article itself warns that absolute risks change from one group of patients to another and from one surgical series to another. That is why it was designed mainly to compare one patient's risk with another's.4

CAPRA uses the biopsy and rectal exam and does not include the MRI or the PSMA PET. Neither score knows about your health, other illnesses, your urine and erections today or what you want to preserve. So the result helps you understand the size of the risk and does not tell you which treatment to have. For the risk group from the European guideline table, use the risk group calculator.

My approach

At diagnosis, I review the biopsy report, your PSA history, the rectal exam, the MRI and, when indicated, the PSMA PET, and I explain which group your case is in and what the studies show for it. I do not recommend active surveillance for intermediate risk, including favourable intermediate risk. When surgery is the way forward, I perform robotic radical prostatectomy and decide on lymph node removal using the Briganti nomogram. For intermediate and high risk, when I recommend surgery, I advise operating as soon as possible.

After surgery, I explain at the consultation what the pathology report shows. The first PSA is done at about 1 month, and follow-up continues as I explain on the page on PSA after prostatectomy. With a positive margin and an undetectable PSA, I monitor the PSA, as the European guideline advises.6 If you would like another opinion, a second opinion can be done entirely online, in English. The site's other tools are on the calculators page.

Send your case

If you have received a diagnosis or have already had surgery and would like my opinion on your case, fill in the form below. It goes to my office, and you will get a reply within 24 hours by email or WhatsApp. The form does not replace a consultation: it helps plan the next step.

Frequently asked questions

What is the CAPRA score?

It is a score from 0 to 10 developed at the University of California, San Francisco (UCSF) and published in 2005. It adds up points for the PSA, the biopsy Gleason score, the clinical stage, the percentage of cores with cancer and age, and it was designed to predict recurrence after prostatectomy.1 In a 2009 study of 10,627 men, the 0 to 2, 3 to 5 and 6 to 10 groups also separated the risk of metastasis and death from prostate cancer.2

What is the difference between CAPRA and CAPRA-S?

CAPRA is calculated at diagnosis, from the biopsy. CAPRA-S, published in 2011, is calculated after prostatectomy, from the pathology report of the removed prostate. It uses the PSA before surgery, the Gleason score of the specimen, the margin, extracapsular extension, seminal vesicle invasion and the lymph nodes, and it ranges from 0 to 12 points.1,4

What does a CAPRA score of 0 to 2, 3 to 5 or 6 to 10 mean?

These are the low, intermediate and high risk groups. In the 2009 study, which included men treated in different ways, 97.1% of the low group, 91.6% of the intermediate group and 79.1% of the high group had not died of prostate cancer at 10 years.2

Does CAPRA replace the European guideline risk group?

They look at the same case in different ways. The European guideline defines the group with its own table, using the PSA, the ISUP grade group, the stage on rectal exam and the lymph nodes.5 CAPRA adds up points and also includes age and the percentage of cores with cancer.2 The guideline risk group calculator is also on this site.

Does a high CAPRA-S score mean the cancer will come back?

It means the risk is higher than with a low score. In the 2011 study, among men with 6 points, 49.2% were free of progression at 3 years. The article itself says that absolute numbers vary from one centre to another and that CAPRA-S is mainly a way of comparing risks.4

How much does a positive margin count in CAPRA-S?

It is worth 2 points, the same as seminal vesicle invasion. The points came from the weight of each factor in the statistical model of the 2011 study.4 In my practice, with a positive margin and an undetectable PSA, I monitor the PSA, as the European guideline advises.6

Who can assess prostate cancer risk before and after surgery in São Paulo?

I see men with prostate cancer in São Paulo, at diagnosis and after surgery. I am Dr. Petronio Melo, a urologist and robotic surgeon, CRM-SP 157.598 and RQE 70.275, and a reference in prostate cancer. I hold a PhD from the University of São Paulo Medical School, with award-winning research on artificial intelligence in prostate cancer diagnosis, and I have performed more than 1,500 robotic and laparoscopic surgeries, more than 500 of them robotic. At the consultation, I review the biopsy, the scans and, after prostatectomy, the pathology report. My office is in Vila Mariana, and the first consultation can be in person or online, in English.

References

  1. Cooperberg MR, Pasta DJ, Elkin EP, et al. The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy. J Urol. 2005;173(6):1938-1942. PubMed
  2. Cooperberg MR, Broering JM, Carroll PR. Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis. J Natl Cancer Inst. 2009;101(12):878-887. PubMed
  3. Cooperberg MR, Freedland SJ, Pasta DJ, et al. Multiinstitutional validation of the UCSF cancer of the prostate risk assessment for prediction of recurrence after radical prostatectomy. Cancer. 2006;107(10):2384-2391. PubMed
  4. Cooperberg MR, Hilton JF, Carroll PR. The CAPRA-S score: A straightforward tool for improved prediction of outcomes after radical prostatectomy. Cancer. 2011;117(22):5039-5046. PubMed
  5. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer: classification and staging systems (table 4.3). European Association of Urology; 2026. EAU
  6. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer: treatment. European Association of Urology; 2026. EAU

Would you like to talk about your case?

In the consultation, I go over your tests and your priorities.

Book a consultation5.0186 Google reviews

Related guides